Bouchey Financial Group Ltd Has $296,000 Stock Position in Danaher Co. (NYSE:DHR)

Bouchey Financial Group Ltd raised its stake in Danaher Co. (NYSE:DHR) by 60.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,290 shares of the conglomerate’s stock after buying an additional 486 shares during the period. Bouchey Financial Group Ltd’s holdings in Danaher were worth $296,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Financial Security Advisor Inc. boosted its position in Danaher by 27.4% in the fourth quarter. Financial Security Advisor Inc. now owns 4,207 shares of the conglomerate’s stock valued at $966,000 after buying an additional 905 shares in the last quarter. Fort Sheridan Advisors LLC raised its stake in shares of Danaher by 43.4% during the fourth quarter. Fort Sheridan Advisors LLC now owns 1,186 shares of the conglomerate’s stock valued at $272,000 after acquiring an additional 359 shares during the last quarter. Peloton Wealth Strategists raised its stake in shares of Danaher by 3.5% during the fourth quarter. Peloton Wealth Strategists now owns 5,696 shares of the conglomerate’s stock valued at $1,308,000 after acquiring an additional 190 shares during the last quarter. Versor Investments LP bought a new position in shares of Danaher during the fourth quarter valued at $292,000. Finally, Proficio Capital Partners LLC raised its stake in shares of Danaher by 29,287.7% during the fourth quarter. Proficio Capital Partners LLC now owns 588,929 shares of the conglomerate’s stock valued at $135,189,000 after acquiring an additional 586,925 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analysts Set New Price Targets

DHR has been the subject of several analyst reports. The Goldman Sachs Group set a $250.00 price target on shares of Danaher in a research note on Wednesday, January 15th. Scotiabank initiated coverage on shares of Danaher in a research note on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price target for the company. Jefferies Financial Group dropped their price target on shares of Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research note on Wednesday, January 29th. JPMorgan Chase & Co. dropped their price target on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, Barclays dropped their price target on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $278.00.

Insider Activity

In other news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Danaher Trading Down 1.8 %

NYSE:DHR opened at $205.69 on Friday. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $147.01 billion, a price-to-earnings ratio of 38.96, a PEG ratio of 2.66 and a beta of 0.83. The firm has a fifty day simple moving average of $225.00 and a two-hundred day simple moving average of $245.50. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the business earned $2.09 earnings per share. Analysts expect that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.62%. The ex-dividend date of this dividend is Friday, March 28th. Danaher’s dividend payout ratio (DPR) is currently 24.24%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.